Search research articles
Contact Us
Filters
Showing results (331-340 of 548) with videos related to
Page
of 55
Sort By:
Psychopharmacology
|
January 1, 1985
Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats
K Murugaiah, A Theodorou, A Clow, et al.
European Journal of Pharmacology
|
November 4, 1986
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats
M L De Ceballos, S Boyce, P Jenner, et al.
The Journal of Pharmacy and Pharmacology
|
April 1, 1976
Contraversive circling behaviour produced by unilateral electrolytic lesions of the ventral noradrenergic bundle mimicking the changes seen with unilateral electrolytic lesions of the locus coeruleus
I M Donaldson, A Dolphin, P Jenner, et al.
Nature Reviews. Neuroscience
|
August 3, 2001
Failure of the ubiquitin-proteasome system in Parkinson's disease
K S McNaught, C W Olanow, B Halliwell, et al.
The Journal of Pharmacy and Pharmacology
|
January 1, 1977
The effect of diphenylhydantoin on central catecholamine containing neuronal systems
P N Elliott, P Jenner, D Chadwick, et al.
British Journal of Pharmacology
|
July 1, 1976
Substituted benzamides as dopamine antagonists [proceedings]
P N Elliott, G Huizing, P Jenner, et al.
The Journal of Pharmacy and Pharmacology
|
January 1, 1978
A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs
P Jenner, P N Elliott, A Clow, et al.
Biochemical and Biophysical Research Communications
|
November 21, 1997
Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease
K A Marshall, S E Daniel, N Cairns, et al.
Neuroscience Letters
|
July 4, 1985
Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset
A Fine, G P Reynolds, N Nakajima, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 1, 1980
Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa
M Schachter, C D Marsden, J D Parkes, et al.
Page
of 55
Search research articles
Search
Showing results (331-340 of 548) with videos related to
Sort By:
Page
of 55
Psychopharmacology
|
January 1, 1985
Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats
K Murugaiah, A Theodorou, A Clow, et al.
European Journal of Pharmacology
|
November 4, 1986
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats
M L De Ceballos, S Boyce, P Jenner, et al.
The Journal of Pharmacy and Pharmacology
|
April 1, 1976
Contraversive circling behaviour produced by unilateral electrolytic lesions of the ventral noradrenergic bundle mimicking the changes seen with unilateral electrolytic lesions of the locus coeruleus
I M Donaldson, A Dolphin, P Jenner, et al.
Nature Reviews. Neuroscience
|
August 3, 2001
Failure of the ubiquitin-proteasome system in Parkinson's disease
K S McNaught, C W Olanow, B Halliwell, et al.
The Journal of Pharmacy and Pharmacology
|
January 1, 1977
The effect of diphenylhydantoin on central catecholamine containing neuronal systems
P N Elliott, P Jenner, D Chadwick, et al.
British Journal of Pharmacology
|
July 1, 1976
Substituted benzamides as dopamine antagonists [proceedings]
P N Elliott, G Huizing, P Jenner, et al.
The Journal of Pharmacy and Pharmacology
|
January 1, 1978
A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs
P Jenner, P N Elliott, A Clow, et al.
Biochemical and Biophysical Research Communications
|
November 21, 1997
Upregulation of the anti-apoptotic protein Bcl-2 may be an early event in neurodegeneration: studies on Parkinson's and incidental Lewy body disease
K A Marshall, S E Daniel, N Cairns, et al.
Neuroscience Letters
|
July 4, 1985
Acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine affects the adrenal glands as well as the brain in the marmoset
A Fine, G P Reynolds, N Nakajima, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 1, 1980
Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa
M Schachter, C D Marsden, J D Parkes, et al.
Page
of 55